Stellartech Research

Executive Summary

Stellartech Research Corporation is a privately held, US-based medical device contract research, development, and manufacturing organization (CDMO) headquartered in Fremont, California. Founded in 1986, the company specializes in designing, developing, and manufacturing sophisticated medical systems that leverage radiofrequency, ultrasound, and other therapeutic energy sources. Stellartech partners with companies of all sizes, providing end-to-end services from concept through regulatory approval and production. Additionally, it incubates 'virtual companies' for entrepreneurs and physicians, enabling rapid prototyping and commercialization of novel medical technologies. With nearly four decades of experience, Stellartech has established itself as a reliable CDMO in the therapeutic energy space, serving a diverse client base. Its long track record and deep technical expertise position it well to capitalize on the growing demand for minimally invasive and energy-based therapies. While the company remains private and does not disclose financials, its sustained presence in the competitive Bay Area CDMO market suggests steady operations. Key growth drivers include the expansion of its client portfolio and potential scaling of manufacturing capabilities to meet increasing demand from both established medical device firms and startup incubations.

Upcoming Catalysts (preview)

• Q3 2026New CDMO contract with a top-10 medical device company65% success
• Q4 2026Completion of facility expansion to double manufacturing capacity70% success
• Q2 2026FDA 510(k) clearance for a client's RF ablation system developed by Stellartech75% success